The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
Public ClinicalTrials.gov record NCT02700464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma: A Multicenter, Prospective Blinded Pivotal Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Clinical trial to determine the efficacy (sensitivity and specificity) of the Bladder EpiCheck test compared to the gold standard cystoscopy and pathology in patients under monitoring for recurrence of bladder cancer.
Study identification
- NCT ID
- NCT02700464
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Interventions
- Bladder EpiCheck Urine Test Device
- Cystoscopy and pathology Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2016 (Actual)
- Primary completion
- Apr 2020 (Actual)
- Completion
- Jul 2020 (Actual)
- Last update posted
- May 4, 2021
2016 – 2020
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| Chesapeake Urology Research Associates | Baltimore | Maryland | 21237 | — |
| Michigan Institute of Urology, P.C. | Troy | Michigan | 48084 | — |
| Metro Urology | Woodbury | Minnesota | 55125 | — |
| Urological Surgeons of Long Island | Garden City | New York | 11530 | — |
| Duke University Health System | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Urology San Antonio | San Antonio | Texas | 78229 | — |
| University Of Washington | Seattle | Washington | 98195-6158 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02700464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2021 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02700464 live on ClinicalTrials.gov.